Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders
EP1688161A1
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
EP1666075A1
Wound dressing compositions, especially for delivery of protease inhibitors
EP1652841A1
Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes
WO2004096222A1
Use of 1-(5-isoquinolinesulfonyl)homopiperazine, its active metabolites, isomers and salts for treating and preventing hypopigmentary disorders
EP1602365A1
Pharmaceutical composition for topical use in form of xerogels or films and methods for production
EP1550446A1
Use of 1-(5-isoquinolinesulfonyl) homopiperazine for treating and preventing hypopigmentary disorders
DE10324997A1
Mrp8 / Mrp14 inhibitors and their use for the prevention and / or treatment of hypertrophic scars and keloids
EP1479386A1
Use of isoquinoline-derivatives for treating and preventing pigmentary disorders
AU2003212293A1
Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
DE10250870A1
Composition containing activators of IK potassium channels and calcineurin antagonists and their use
EP1415664A1
Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
AU2002341207A1
Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
WO02088181A2
Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
EP1392354A2
Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds
EP1340507A1
Use of fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing
EP1345618A2
Chlorzoxazone for the treatment of psoriasis
CA2354253A1
Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances
EP1176200A2
Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
DE10122206A1
Novel use of 2',5'-oligoadenylate synthetase or RNAseL polypeptides, nucleic acids encoding polypeptides, cell expressing peptides and nucleic acids or antibody for analyzing, diagnosing, or treating wound healing
